Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) · 1 day ago
Senior Manager, Drug Product Development
Arcutis Biotherapeutics, Inc. is a pioneering medical dermatology company dedicated to revolutionizing the treatment of serious skin diseases. The Senior Manager, Drug Product Development will lead formulation and drug product deliverables, support pre-clinical and clinical studies, and collaborate with internal and external partners to drive product development and regulatory submissions.
BiopharmaBiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Lead formulation, Device, and Drug Product deliverables to support pre-clinical, clinical/pivotal studies leading to IND, BLA/MAA and commercial launch
Evaluate molecules for CQAs by the means of accelerated conditions and stress exposures, characterizing molecule variants and degradants
Plan, design and execute univariate/multivariate formulation and DP process characterization/validation studies with external testing sites, and drive timely execution with quality oversight
Guide CRO in analytical testing with chromatographic and biophysical methods (e.g. SEC-MALS, DLS, spectroscopy etc.) to support product and process characterization
Devise the DP and Device process technology transfer, qualification, and validation strategy, for clinical/commercial product site transfer
Provide on-going fill-finish manufacturing support to Drug Product sites/CMOs: including technology transfers and impact assessments, during quality investigations to ensure product and process consistency
Partner with internal/external manufacturing and quality for process improvement, transfers, compilation and review of batch records, master production records and technical support to resolve investigations, deviations, corrective/preventative actions
Author and review technical protocols and reports, to document study findings in support of Investigational New Drug (IND), IND amendments, BLA/MAA and other global regulatory filings
Participate in CMC/project teams for functional representation as well as support teams’ objectives and project deliverables
Evaluate biochemical and biophysical methods suitable for MaB and fusion protein molecular assessment and product characterization
Collaborate with full-time employees, contractors, and consultants, to deliver organizational goals
Qualification
Required
Ph.D. in biochemistry, pharmaceutical sciences, biochemical engineering, or related discipline and 5+ years of product development experience in industry or BS/MS with 10+ years of experience
Experience with biologics formulation development, Drug Product process design, Device development, and manufacturing Fill/Finish
Excellent communication (oral and written) and attention to detail, ability to work independently and as part of a team, self-motivation, adaptability, and a positive attitude
Preferred
Experience with MaB or fusion protein process/formulation/analytical development
Sound understanding of analytical methods for formulation characterization (e.g. qPCR/ddPCR, UV-vis, H/UPLC, capillary electrophoresis and biophysical techniques (e.g. SEC-MALS, DLS, AUC, Fluorescence, particle analysis, etc.)
Experience in QbD methodologies and statistical analysis using JMP
Good knowledge of FDA guidance as well as cGMP and ICH requirements
Experience or contribution to regulatory submissions, through any phase of product development
Travel may be required for up to 25% of time worked
Company
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology.
Funding
Current Stage
Public CompanyTotal Funding
$833.5MKey Investors
SLR Capital PartnersHBM Healthcare InvestmentsOrbiMed
2024-02-28Post Ipo Equity· $150M
2023-10-19Post Ipo Equity· $100M
2022-08-02Post Ipo Equity
Leadership Team
Recent News
The Motley Fool
2025-12-14
2025-11-22
Company data provided by crunchbase